Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-12

Clinical Trial Update: Dalpiciclib Combined With Endocrine Therapy and Metronomic Capecitabine vs Dalpiciclib Combined With Endocrine Therapy for First-line Treatment [Phase 3]

View source ↗

Summary

Phase 3 trial assessing dalpiciclib plus endocrine therapy with or without metronomic capecitabine as first-line treatment for breast cancer; currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Capecitabine (capecitabine)
  • Dalpiciclib (dalpiciclib)
  • Endocrine therapy

Snippet

Sponsor: Fujian Cancer Hospital | Conditions: Breast Cancer | Phase 3 | Status: RECRUITING